Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Alzheimer’s Study Targets Early Memory Loss
Uncategorized

Alzheimer’s Study Targets Early Memory Loss

By medwebJan 7, 2011
Share
Facebook Twitter Email

Alzheimer’s Study Targets Early Memory Loss

Northwestern University Feinberg School of Medicine is enrolling participants for the first national study Video to detect Alzheimer’s disease in older people before they begin to have significant memory loss.

Researchers will use imaging techniques and biomarker measures in blood and cerebrospinal fluid specially developed to track changes in the living brain. The goal is to identify who is at risk for Alzheimer’s, track progression of the disease, and devise tests to measure the effectiveness of potential interventions.

Northwestern Medicine’s Cognitive Neurology and Alzheimer’s Disease Center (CNADC) is one of several study sites led by the National Institute on Aging. The study is an expansion of the National Institutes of Health’s Alzheimer’s Disease Neuroimaging Initiative.

“This is an important study to develop ways physicians can detect the disease before the person has overt memory loss,” said Diana Kerwin, MD, the principal investigator of the study at CNADC and assistant professor of geriatrics at Feinberg. “The earlier we can detect disease the better chance there is to prevent or delay the memory loss from happening at all. Early diagnosis is really going to be key as far as making any further breakthroughs into the treatment of Alzheimer’s disease and other memory disorders.”

Potential participants include men and women aged 55 to 90 with early signs of memory loss that does not currently affect their daily lives. Participants without signs of cognitive problems also can enroll in the control group of the study.

“By taking part in the study, someone who has Alzheimer’s disease in their family or is concerned about their own memory would be contributing to our scientific understanding of the early markers of Alzheimer’s disease pathology in the brain and also normal aging,” Kerwin said.

Another important aspect of the study is the sharing of data soon after it is obtained. Imaging data is posted to a publicly accessible database available to qualified researchers worldwide.

To find out more about this study, contact Kristine Lipowski, the study’s project coordinator, at (312) 503-2486.

Alzheimer’s Disease Neuroimaging Initiative is funded by the National Institutes of Health, The Food and Drug Administration, pharmaceutical, imaging, and clinical trial management companies and nonprofit organizations, including the Alzheimer’s Association and Alzheimer’s Drug Discovery Foundation, as well as from private donations.

Members of the media, please contact Erin White via e-mail or at (847) 491-4888 for more information about this story.

Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Comments are closed.

Latest News

Self-Powered Wireless Implant Delivers Medication, Then Dissolves

Mar 30, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.